156 related articles for article (PubMed ID: 20830241)
21. Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts.
Zhou YD; Kim YP; Li XC; Baerson SR; Agarwal AK; Hodges TW; Ferreira D; Nagle DG
J Nat Prod; 2004 Dec; 67(12):2063-9. PubMed ID: 15620252
[TBL] [Abstract][Full Text] [Related]
22. Microneedle-mediated intradermal delivery of epigallocatechin-3-gallate.
Puri A; Nguyen HX; Banga AK
Int J Cosmet Sci; 2016 Oct; 38(5):512-23. PubMed ID: 27009797
[TBL] [Abstract][Full Text] [Related]
23. EGCG decreases the expression of HIF-1α and VEGF and cell growth in MCF-7 breast cancer cells.
Luo HQ; Xu M; Zhong WT; Cui ZY; Liu FM; Zhou KY; Li XY
J BUON; 2014; 19(2):435-9. PubMed ID: 24965403
[TBL] [Abstract][Full Text] [Related]
24. Effects of EGCG on proliferation and apoptosis of gastric cancer SGC7901 cells via down-regulation of HIF-1α and VEGF under a hypoxic state.
Fu JD; Yao JJ; Wang H; Cui WG; Leng J; Ding LY; Fan KY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):155-161. PubMed ID: 30657557
[TBL] [Abstract][Full Text] [Related]
25. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin.
Katiyar SK; Matsui MS; Elmets CA; Mukhtar H
Photochem Photobiol; 1999 Feb; 69(2):148-53. PubMed ID: 10048310
[TBL] [Abstract][Full Text] [Related]
26. A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer.
Wang J; Man GCW; Chan TH; Kwong J; Wang CC
Cancer Lett; 2018 Jan; 412():10-20. PubMed ID: 29024813
[TBL] [Abstract][Full Text] [Related]
27. Photodegradation of (-)-epigallocatechin-3-gallate in topical cream formulations and its photostabilization.
Bianchi A; Marchetti N; Scalia S
J Pharm Biomed Anal; 2011 Dec; 56(4):692-7. PubMed ID: 21807473
[TBL] [Abstract][Full Text] [Related]
28. Epigallocatechin-3-gallate promotes angiogenesis via up-regulation of Nfr2 signaling pathway in a mouse model of ischemic stroke.
Bai Q; Lyu Z; Yang X; Pan Z; Lou J; Dong T
Behav Brain Res; 2017 Mar; 321():79-86. PubMed ID: 28042007
[TBL] [Abstract][Full Text] [Related]
29. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
[TBL] [Abstract][Full Text] [Related]
30. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC
Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482
[TBL] [Abstract][Full Text] [Related]
31. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
[TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin-3-gallate attenuates acute and chronic psoriatic itch in mice: Involvement of antioxidant, anti-inflammatory effects and suppression of ERK and Akt signaling pathways.
Guo R; Zhou FM; Su CJ; Liu TT; Zhou Y; Fan L; Wang ZH; Liu X; Huang Y; Liu T; Yang J; Chen LH
Biochem Biophys Res Commun; 2018 Feb; 496(4):1062-1068. PubMed ID: 29402411
[TBL] [Abstract][Full Text] [Related]
33. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress.
Katiyar SK; Afaq F; Perez A; Mukhtar H
Carcinogenesis; 2001 Feb; 22(2):287-94. PubMed ID: 11181450
[TBL] [Abstract][Full Text] [Related]
34. Epigallocatechin gallate relieves asthmatic symptoms in mice by suppressing HIF-1α/VEGFA-mediated M2 skewing of macrophages.
Yang N; Li X
Biochem Pharmacol; 2022 Aug; 202():115112. PubMed ID: 35640712
[TBL] [Abstract][Full Text] [Related]
35. Green tea and its anti-angiogenesis effects.
Rashidi B; Malekzadeh M; Goodarzi M; Masoudifar A; Mirzaei H
Biomed Pharmacother; 2017 May; 89():949-956. PubMed ID: 28292023
[TBL] [Abstract][Full Text] [Related]
36. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
Zhou H; Fu LX; Li L; Chen YY; Zhu HQ; Zhou JL; Lv MX; Gan RZ; Zhang XX; Liang G
J Ethnopharmacol; 2020 Oct; 261():113118. PubMed ID: 32621953
[TBL] [Abstract][Full Text] [Related]
37. Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin.
Vayalil PK; Elmets CA; Katiyar SK
Carcinogenesis; 2003 May; 24(5):927-36. PubMed ID: 12771038
[TBL] [Abstract][Full Text] [Related]
38. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
[TBL] [Abstract][Full Text] [Related]
39. EGCG, a major component of green tea, inhibits VEGF production by swine granulosa cells.
Basini G; Bianco F; Grasselli F
Biofactors; 2005; 23(1):25-33. PubMed ID: 15817996
[TBL] [Abstract][Full Text] [Related]
40. (-)-Epigallocatechin-3-gallate in Camellia sinensis leaves from Himalayan region of Sikkim: inhibitory effects against biochemical events and tumor initiation in Sencar mouse skin.
Katiyar SK; Agarwal R; Wang ZY; Bhatia AK; Mukhtar H
Nutr Cancer; 1992; 18(1):73-83. PubMed ID: 1408948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
